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Objectives. We sought to determine the effects of secondhand
smoke (SHS) exposure on vascular reactivity in newborn and
infant rats.
Background. Secondhand smoke exposure increases cardiovas-
cular risk. Secondhand smoke–induced endothelial dysfunction
has been demonstrated in older teenagers and young adults. We
have previously shown in adult rabbits that SHS induces athero-
genesis and endothelial dysfunction. The effects of SHS on vascu-
lar function in the offspring of SHS-exposed mothers and in
infants are unknown.
Methods. In this study the effects of in-utero (21 days) and
neonatal (28 days) exposure to SHS were examined in 80 rats, 4
weeks of age, in a 2-by-2 design study. Rats were exposed to
sidestream smoke in smoking chambers. Aortic rings were excised
and isometric force responses to phenylephrine, acetylcholine,
A23187 and nitroglycerin were studied in organ baths.
Results. Neonatal SHS exposure reduced animal weight (p 5
0.009). In-utero exposure increased the sensitivity (decreased the
EC50) of aortic rings to phenylephrine (p < 0.0005), as did
neonatal exposure (p 5 0.01). Maximal contraction to phenyleph-
rine was reduced by in-utero exposure (p 5 0.04). In-utero SHS
exposure reduced maximal endothelium-dependent relaxation to
acetylcholine (p 5 0.04) and increased the EC50 (p 5 0.05),
suggesting impaired sensitivity to acetylcholine. In-utero exposure
decreased the sensitivity (increased the EC50) to the endothelium-
independent vasodilator nitroglycerin (p 5 0.003).
Conclusions. Secondhand smoke has detrimental effects on
vascular smooth muscle function in the newborn.
(J Am Coll Cardiol 1998;32:1463–7)
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Secondhand tobacco smoke (SHS) is the third largest prevent-
able public health risk after active smoking and alcohol (1).
Epidemiologic studies demonstrate an increase in coronary
artery disease events and mortality with exposure to SHS (2).
There is increasing concern about the potential impact of
tobacco-related disease before adulthood. Secondhand smoke
exposure in childhood reduces high-density lipoprotein levels
(3). In teenagers and young adults SHS exposure impairs
endothelium-dependent relaxation (4). The American Heart
Association has formally concluded that SHS constitutes an
important health risk for both adults and children (5). It is not
known whether exposure to SHS even earlier in life, such as in
utero or in infancy, or both, causes vascular dysfunction.
Tobacco smoke metabolites such as cotinine can be recov-
ered in the meconium and hair of neonates whose mothers had
been exposed to SHS (6,7). Nursing mothers exposed to SHS
also transfer cotinine and possibly other toxins from tobacco
smoke to infants through breast milk (8,9). This study sought
to determine the effect of SHS on the vasculature of infant rats
whose mothers had been exposed to SHS during pregnancy, on
the vasculature of rats exposed as neonates and the effects of
SHS on neonatal weight.
Methods
Protocol. The study protocol was approved by the Com-
mittee for Animal Research of the University of California at
San Francisco and was performed in accordance with the
recommendations of the American Association for Accredita-
tion of Laboratory Animal Care. Pregnant rats were housed in
separate cages, and after delivery mother rats were also housed
in separate cages with their pups. Baby rats were randomly
assigned to receive, or not to receive, SHS exposure in four
groups: 1) those whose mothers were exposed to SHS while
pregnant (21 days) (SHSU); 2) those whose mothers were
exposed to SHS while pregnant, and who were then exposed to
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SHS 4 weeks after birth (SHSUN); 3) those whose mothers had
not been exposed to SHS during gestation (21 days), but who
were then exposed for the first 4 weeks of life (SHSN); and 4)
those whose mothers had not been exposed to SHS and who
were not exposed during the first 4 weeks of life (controls).
Each mother gave birth to eight or nine pups.
As we have previously described, rats were exposed to
cigarette sidestream smoke using a smoking machine in smok-
ing chambers (10). Rats were housed in individual cages. Rats
randomized to SHS were placed in SHS exposure chambers
(BioClean, Duo. Flo, model H 5500; Lab Products Inc.) that
measured 1.92 3 1.92 3 0.97 m (3.58 m3) and accommodated
eight rats at a time. Rats were exposed to sidestream smoke
from Marlboro filter cigarettes (four cigarettes every 15 min
for 6 h/day, 5 days/week) using a smoking machine (Heinr,
Borgwald GMBH RM 1/G, Hamburg, Germany) for 10 weeks,
from week 3 to week 13. Three fans in the exposure chambers
were adjusted to ensure good mixing of the air within them. At
the end of the 6-h exposure period the exhaust fan on the
BioClean unit was turned on. This rapidly lowered the level of
SHS pollution in the exposure chamber to background levels
corresponding to those of the non–SHS-exposed animals until
the next day when the BioClean unit was turned off and the
smoking machine was turned on again. Rats randomized to
nonexposure were housed in separate cages in the same type of
exposure chamber in another room, but without a smoking
machine.
At week 4 after birth rats were sacrificed by lethal injection
with intravenous pentobarbital, 130 mg/kg body weight. The
age of 4 weeks was chosen because rats of this age weighed
approximately 100 g and had aortas of sufficient size to be
easily studied in organ baths. Aortas from the largest 20 pups
from each group were studied (n 5 20 all groups). One arterial
ring segment (1 to 2 mm in diameter and 5 mm in length) was
rapidly excised starting from the descending thoracic aorta.
Rings were taken from the same position in the aorta for each
study.
Vascular reactivity studies. Each ring was suspended hor-
izontally between two parallel stainless steel wires to measure
isometric force in individual organ baths containing Krebs
solution at 37°C. Isometric force generated by the ring segment
was recorded continuously as previously described (10).
Ring segments were stabilized at 1 g rest force for 60 min
before being studied. This rest force was determined in a prior
series of organ bath experiments which determined that this
rest tension allowed for the greatest tension changes with
vasoactive agents. To measure responsiveness to phenyleph-
rine (Phe) and to calculate the dose needed for precontraction
for relaxation dose–response curves for each individual ring,
Phe in increasing doses (from 1029 to 1024 mol/L) was added
to each ring/bath. For each ring the dose needed to achieve
half-maximal contraction (EC50Phe) was calculated. After the
Phe contraction series the baths were washed out three times
with fresh Krebs solution and the rings were allowed to
stabilize for 1 h. To study endothelium-derived nitric oxide–
mediated vasorelaxation, aortic rings that had been precon-
tracted with the EC50Phe for that ring were exposed to the
endothelium-dependent vasodilator acetylcholine (doses from
1029 to 1024.5 mol/L) and later to the muscarinic receptor-
independent endothelium-dependent vasodilator calcium
ionophore A23187. Lastly, each ring was precontracted and
exposed to the endothelium-independent relaxation agent
nitroglycerin (doses from 1029 to 1025 mol/L). At the end of
each series the baths were washed out twice with fresh Krebs
solution and the rings were allowed to stabilize at baseline
force. Vascular reactivity experiments were performed by an
investigator who was unaware of the treatment group.
Drugs and their sources. Phenylephrine, acetylcholine and
the calcium ionophore A23187 were purchased from Sigma
Corp. (St. Louis, Missouri). Nitroglycerin was purchased from
Solopak Laboratories Inc. (Elk Grove, Illinois). Distilled water
was used as the solvent for all agents other than A23187, which
was dissolved in dimethyl sulfoxide to create a stock solution of
A23187, which was then sequentially diluted with distilled
water.
Serum nicotine and cotinine. Serum nicotine and cotinine
levels were measured in an additional 26 rats at 4 weeks after
birth (six or seven rats per group) using nitrogen–phosphorus
gas chromatography.
Statistical analysis. All results are expressed as mean 6
SEM unless otherwise indicated. The response to Phe was
expressed as change in force from baseline (grams) and
recorded and analyzed as described previously. Relaxation of
aortic rings is expressed as percentage change of net developed
force (measured force 2 baseline force)/(precontracted
force 2 baseline force), EC50 and slope. Slope, expressed by
the Hill coefficient, was calculated using commercially avail-
able software (Kaleidagraph; Abelbeck Software) that resolved
a curve of best fit to each ring’s dose–response relationship.
Slope was calculated to describe sensitivity to vasoactive
substances. The effects of in-utero and neonatal SHS exposure
on vascular reactivity and animal weight were evaluated using
a two-way analysis of variance, including main effects in-utero
exposure (present or absent) and neonatal exposure (present
or absent), using a general linear model and commercially
available software (Minitab 10.51; Minitab Inc., State College,
Pennsylvania). Differences in birth mortality were assessed
using the chi-square test. A p value of less than 0.05 was
considered significant.
Results
Birth mortality was greater in rats exposed in utero than in
rats not exposed in utero (12% vs. 3%; p , 0.001). Neonatal
Abbreviations and Acronyms
EC50 5 concentration for half-maximal contraction
Phe 5 phenylephrine
SHS 5 secondhand smoke
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SHS exposure was associated with reduced average body
weight (104 6 0.4 vs. 111 6 0.4 g; p 5 0.009) at 4 weeks.
In-utero exposure did not influence body weight when mea-
sured at 4 weeks (107 6 0.4 vs. 108 6 0.4 g; p 5 0.97). Neonatal
SHS-exposed rats had significantly greater plasma cotinine
(437 6 124 ng/ml vs. undetectable; i.e., ,0.1 ng/ml; p ,
0.0001) and nicotine (39 6 5 ng/ml vs. undetectable; p ,
0.0001) levels, confirming the presence of tobacco-related
compounds in the circulation of the newborn rats.
Mean dose–response curves to Phe are plotted in Figure
1A. In-utero and neonatal exposures were both associated with
increased sensitivity (lesser EC50) to Phe (Fig. 1B, Table 1).
In-utero exposure reduced maximal contraction to Phe (p 5
0.04). There was a significant interaction between in-utero and
neonatal smoke exposure on the EC50 of Phe, indicating that
the effect of in-utero SHS exposure on sensitivity of smooth
muscle contraction was dominant over the effect of neonatal
SHS. In-utero SHS exposure reduced maximal acetylcholine-
induced endothelium-dependent relaxation (Fig. 2A, Table 2).
In-utero exposure tended to increase the EC50 of the dose–
response curves to A23187 (Fig. 2B), suggesting reduced
sensitivity to this endothelium-dependent vasorelaxing agent.
In-utero SHS exposure also caused a rightward shift of the
dose–response curves to nitroglycerin, indicating reduced
smooth muscle sensitivity in response to an endothelium-
independent relaxing agent (Fig. 3A and B).
Other than the interaction term described above, none of
the interaction terms of the general linear model analysis of
variance achieved significance, indicating that the effects of
in-utero exposure did not modify the effects of neonatal
exposure, or vice versa.
Discussion
This is the first study to present evidence that maternal SHS
exposure during pregnancy and neonatal SHS exposure cause
abnormal vasoconstrictor and vasodilator responses in infant
rats. The 21-day gestational period of rats was sufficient for
these vascular abnormalities to develop. We have previously
shown in adult rabbits that 10 weeks of exposure to SHS at the
same dose caused abnormalities of endothelial function (10),
and that 6 weeks of SHS exposure of adult rats increased
myocardial infarct size (11). The shorter period in which
vascular abnormalities were seen in baby rats suggests that the
developing cardiovascular system may be even more sensitive
to the injurious influences of tobacco smoke exposure. The
impairment of endothelium-dependent vasorelaxation in the
context of concurrent abnormalities of endothelium-
independent relaxation suggests that smooth muscle dysfunc-
Figure 1. (A) Dose–response curves of rat aortas exposed to Phe. The
dose–response curves of the three groups of SHS-exposed rats are all
shifted to the left of that of the control group, indicating greater
sensitivity to adrenoceptor-mediated contraction. (B) EC50 values for
Phe in the four groups of rats. Both in-utero and neonatal tobacco
smoke exposure reduce the EC50 to Phe. SHSU 5 in-utero second-
hand smoke exposure; SHSN 5 neonatal secondhand smoke exposure;
SHSUN 5 in-utero and neonatal secondhand smoke exposure; Con-
trol 5 no secondhand smoke exposure.
Table 1. Vasocontraction
Group p Value
SHSU SHSUN SHSN Control Utero Natal Utero-Natal
n 20 20 20 20
Maximal D force (g) 2.64 6 0.16 2.68 6 0.18 3.03 6 0.13 2.92 6 0.14 0.038 0.659 0.85
Slope 1.3 6 0.03 1.2 6 0.02 1.1 6 0.03 1.1 6 0.04 0.769 0.820 0.27
The p values presented are the principal effects (“utero” and “natal”) as determined by the general linear model
analysis of variance and the interaction term (“utero 3 natal”). SHSU 5 in-utero secondhand smoke exposure; SHSN 5
neonatal secondhand smoke exposure; SHSUN 5 in-utero and neonatal secondhand exposure; Control 5 no secondhand
smoke exposure.
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tion underlies the observed abnormalities. Enhanced vasocon-
strictor sensitivity in response to Phe was observed in this
study, consistent with published studies of enhanced vasocon-
striction in active smokers (12).
The mechanisms by which maternal and neonatal exposure
to SHS cause the observed vascular abnormalities are unde-
fined. Maternal exposure to SHS results in absorption of
toxins, which are transmitted to the fetus from the mother.
Hair accumulation of cigarette components is reflective of
long-term exposure to tobacco smoke (6). There is a proven
correlation of maternal and neonatal infant hair levels of
nicotine (p , 0.001) and cotinine (p , 0.0001) (6). There is
increased urinary excretion of cotinine by infants who are
breast-fed by mothers exposed to SHS (8); thus infants may be
exposed to SHS toxins by inhalation and also through their diet
if they are breast-fed by a mother exposed to SHS. Maternal
SHS exposure results in similar elevations in meconium nico-
tine metabolite concentrations, as does mild to moderate
maternal active smoking (7), and may therefore be viewed as a
similar toxicologic phenomenon. A recent study by Galanti et
al. (13) suggested that the highest cotinine levels among those
exposed to SHS occur in newborns rather than in exposed
adults and children. Nicotine, cotinine or other vasoactive
substances in tobacco smoke that are transferred to the fetus
and to the nursing infant may adversely influence developing
vascular smooth muscle.
The increasing incidence of tobacco smoking by adolescent
females has engendered rising concern of the long-term health
consequences of tobacco smoke exposure earlier in life. Be-
cause risk of tobacco smoke–induced vascular disease is re-
lated to total lifetime smoke exposure, beginning smoking
earlier in life may increase total lifetime smoke exposure and
therefore risk of vascular disease. Although the data presented
in this study were obtained in an animal model, they do
Figure 2. Endothelium-dependent relaxation. (A) Dose–response
curves of rat aortas exposed to increasing concentration of acetylcho-
line. In-utero SHS exposure reduced maximal relaxation. (B) Dose–
response curves of rat aortas exposed to increasing concentration of
the calcium ionophore A23187. In-utero SHS tended to shift the EC50
of the response to the right, indicating reduced sensitivity.
Table 2. Vasorelaxation
Group p-Value
SHSU SHSUN SHSN Control Utero Natal Utero 3 Natal
n 20 20 20 20
ACh
Max 2102.3 6 3.8 298.6 6 3.6 2105.8 6 2.4 2108 6 3.5 0.04 0.33 0.85
EC50 6.1 3 1028 6 3.5 3 1028 4.6 3 1028 6 9.63 1029 4.6 3 1028 6 9.6 3 1029 4.0 3 1028 6 1.2 3 1028 0.80 0.57 0.22
Slope 1.10 6 0.12 0.97 6 0.11 1.13 6 0.09 0.97 6 0.08 0.75 0.45 0.53
A23187
Max 298 6 4 298 6 3 296 6 3 295 6 3 0.534 0.08 0.69
EC50 1.5 3 1027 6 2.7 3 1028 1.6 3 1027 6 1.1 3 1028 3.8 3 1028 6 3.0 3 1029 3.3 3 1028 6 2.2 3 1028 0.05 0.37 0.18
Slope 2.61 6 0.29 3.4 6 0.60 2.8 6 0.60 5.17 6 1.55 0.13 0.11 0.07
NTG
Max 298 6 3 298 6 4 296 6 3 298 6 3 0.57 0.85 0.88
Slope 0.84 6 0.11 2.61 6 0.30 0.94 6 0.17 1.2 6 0.06 0.36 0.08 0.45
The p values presented are the principal effects (“utero” and “natal”) as determined by the general linear model analysis of variance and the interaction term
(“utero 3 natal”). A23187 5 calcium inophore–induced endothelium-dependent relaxation; ACh 5 acetylcholine-induced endothelium-dependent relaxation; max 5
maximal change in force; NTG 5 nitroglycerin-induced endothelium-independent relaxation other abbreviations as in Table 1.
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indicate that tobacco smoke induces abnormal vascular re-
sponses very early in life. The other major concern engendered
by the increasing incidence of tobacco smoking by adolescent
females pertains to issues of infant health. In this study we
observed greater birth mortality among rats exposed to SHS in
utero and lower body weight in infant rats exposed to SHS.
Previous human studies have demonstrated that maternal
tobacco smoke exposure is injurious to fetuses in utero and to
neonates. Maternal smoke exposure, active or passive, is
associated with preterm labor (14), threatened abortion (14),
increased risk of spontaneous abortion (15) and low birth
weight (16). Secondhand smoke exposure in infants is associ-
ated with sudden infant death syndrome (9).
Study limitations. The data presented in this study are
descriptive. No mechanism for the abnormal vascular re-
sponses was determined. The tobacco smoke exposures (air
nicotine and carbon monoxide) in our model are about twofold
higher than in heavy human smoking environments (17). An
approximate equivalent to the volume of our smoking chamber
(3.6 m2) would be the interior volume of an average automo-
bile sedan (3.7 m2). However, the measurements of plasma
nicotine and cotinine in this study were similar to those of
average smokers (15 to 40 cigarettes/day) (18,19). As our study
was limited to the largest 20 animals of each group, it may have
included bias.
Conclusions. Neonatal SHS exposure retards growth and
results in an increased sensitivity to vasoconstrictive stimuli.
Secondhand smoke exposure to the fetus also causes an
increased sensitivity to vasoconstrictor stimuli and impaired
vasorelaxation. The fetus is not protected in utero from the
effects of SHS, and in fact may be uniquely susceptible to
SHS-induced vascular smooth muscle dysfunction.
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Figure 3. Endothelium-independent relaxation. (A) Dose–response
curves of rat aortas exposed to nitroglycerin. The dose–response curves
of the in-utero SHS exposed rats are all shifted to the right of the
control and neonatal SHS groups. (B) Values of EC50 for nitroglycerin
in the four groups of rats. In-utero tobacco smoke exposure increased
the EC50 to nitroglycerin, indicating less sensitivity to endothelium-
independent relaxation. Abbreviations as in Figure 1.
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